Introduction {#Sec1}
============

Evidence before this study {#Sec2}
--------------------------

Links between environmental chemicals and human health including self-rated health, hypertension, cardiovascular disease, food allergy, oral health, emotional support, and cognitive function in American adults have emerged (Shiue [@CR11], [@CR12], [@CR13], [@CR14], [@CR15], [@CR16], [@CR17], [@CR18], [@CR19]), but the effects from polyaromatic hydrocarbons (PAHs) were less studied, compared to other commonly known environmental chemicals such as heavy metals, arsenic, phenols, and phthalates. PAHs constitute a group of chemicals that people could be exposed via vehicle exhausts, asphalt, coal tar, wild fires, agricultural burning, soil, charbroiled foods, and tobacco smoke. Approximately, everyone could be exposed to PAHs on a daily basis from multiple sources. PAH pollution may have significant health implications, and the extent of damage to organisms from PAH exposure could be dependent on several factors including degrees and types of PAH exposure (Ball and Truskewycz [@CR1]).

Knowledge gap {#Sec3}
-------------

Previously, animal models under a laboratory condition using rodents showed that exposure to PAHs adversely affected immunologic health (Luebke et al. [@CR9]). However, research in this topic from a human sample has not been well conducted. Providing evidence using a human sample might help environmental health promotion in the next few years. Recently, associations of PAHs and cardiovascular, oral, emotional, and self-rated health have been observed (Shiue [@CR15], [@CR16], [@CR17], [@CR18], [@CR19]), but those on digestive health have not been documented. Following this context, therefore, the present study aimed to examine the relationships of urinary PAHs and adult digestive conditions using a large human sample in a national and population-based setting in recent years.

Methods {#Sec4}
=======

Study sample {#Sec5}
------------

As described elsewhere (Centers for Disease Control and Prevention [@CR4]), US National Health and Nutrition Examination Surveys (NHANES) has been a national, population-based, multi-year, cross-sectional study since the 1980s. Study samples are a representative sample of the civilian, non-institutionalized US population. Information on demographics (more details via <http://wwwn.cdc.gov/nchs/nhanes/2011-2012/DEMO_G.htm>), serum cotinine (more details via <http://wwwn.cdc.gov/nchs/nhanes/2011-2012/COTNAL_G.htm>), and self-reported health conditions (more details via <http://wwwn.cdc.gov/nchs/nhanes/2011-2012/MCQ_G.htm>) was obtained by household interview using questionnaires. In the current analysis, the most recent study cohort in 2011--2012 with data on urinary PAHs was selected. Informed consents were obtained from participating subjects by the NHANES researchers.

Biomonitoring {#Sec6}
-------------

Urines were only collected in a subsample, being one third of the whole study cohort with representation (more details via <http://www.cdc.gov/nchs/data/nhanes/nhanes_09_10/homeurine.pdf>), to measure environmental chemical concentrations in urines among people aged 6 and above (more details via <http://www.cdc.gov/nchs/nhanes/nhanes2011-2012/labdoc_g.htm>). Urine specimens from urinary PAH were processed, stored under appropriate frozen (−20 °C) conditions, and shipped to the Division of Environmental Health Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention for analysis. According to the NHANES website (more details via <http://www.cdc.gov/nchs/data/nhanes/nhanes_11_12/PAH_G_met.pdf>), the procedure involved enzymatic hydrolysis of glucuronidated/sulfated OH-polyaromatic hydrocarbons metabolites in urine, extraction, derivatization, and analysis using isotope dilution capillary gas chromatography tandem mass spectrometry (GC-MS/MS). Ion transitions specific to each analyte and carbon-13-labeled internal standards are monitored, and the abundances of each ion are measured. Since urinary PAHs were highly skewed, they were all log transformed when performing the statistical analyses.

Statistical analysis {#Sec7}
--------------------

Adults aged 20 and above were included in the current statistical analysis since chronic diseases were commonly reported in adults. Associations of urinary PAHs and adult self-reported digestive conditions were examined by using *t* test and survey-weighted logistic regression model, presenting with mean values, odds ratios (OR), 95 % confidence intervals (CI), and *P* values. Covariates including urinary creatinine, age, sex, ratio of family income to poverty (proxy of socioeconomic status, calculated by dividing family (or individual) income by the poverty guidelines specific to the survey year; more details via <http://wwwn.cdc.gov/Nchs/Nhanes/2011-2012/DEMO_G.htm>), body mass index, education level, serum cotinine (biomarker of smoking status), alcohol status (\>12 drinks currently or not), and physical activity level (moderate recreational activity or not) were adjusted. In addition, population attributable risks from urinary PAHs, which significant associations were found, were calculated based on the formula introduced by Fleiss ([@CR5]). Statistical software STATA version 13.0 (STATA, College Station, Texas, USA) was used to perform all the analyses.

Ethics consideration {#Sec8}
--------------------

Since there are only secondary data analyses employed without any participant personal information identified by extracting statistical data from the NHANES website in the present study, no further ethics approval for conducting the present study is required (more details via <http://www.ethicsguidebook.ac.uk/Secondary-analysis-106>).

Results {#Sec9}
=======

The characteristics of 5560 American adults aged 20--80 and included in the statistical analysis are shown in Table [1](#Tab1){ref-type="table"}. The presence of different digestive conditions in the American adult population varied since some are common while some are rare. They are shown in Table [2](#Tab2){ref-type="table"}. In Tables [3](#Tab3){ref-type="table"}, [4](#Tab4){ref-type="table"}, [5](#Tab5){ref-type="table"}, [6](#Tab6){ref-type="table"}, [7](#Tab7){ref-type="table"}, [8](#Tab8){ref-type="table"}, [9](#Tab9){ref-type="table"}, [10](#Tab10){ref-type="table"}, and [11](#Tab11){ref-type="table"}, associations of 10 urinary PAHs and adult digestive conditions are presented separately. Specifically, urinary 4-hydroxyphenanthrene was significantly associated with celiac disease (OR 1.61, 95 % CI 1.14--2.26, *P* = 0.009). In addition, urinary 2-hydroxyfluorene (OR 1.35, 95 % CI 1.02--1.78, *P* = 0.038), 3-hydroxyfluorene (OR 1.35, 95 % CI 1.07--1.70, *P* = 0.015), 1-hydroxyphenanthrene (OR 1.48, 95 % CI 1.08--2.03, *P* = 0.017), 1-hydroxypyrene (OR 1.36, 95 % CI 1.05--1.77, *P* = 0.023), and 2-hydroxynapthalene (OR 1.25, 95 % CI 1.00--1.58, *P* = 0.054) were significantly associated with kidney stones, although not necessarily failing kidney. However, there were no statistically significant associations observed in the relationship of urinary PAHs and liver problem, although there were trends toward higher levels of urinary PAHs in people with liver problem. In a subsequent analysis where infection and nutrients were also adjusted, the significant associations have remained (data not shown).Table 1Characteristics of the included participants aged 20--80 (*n* = 5560)Number (%) or mean ± SDAge48.9 ± 17.9 20--391957 (35.2) 40--591812 (32.6) 60--801791 (32.2)Sex Male2740 (49.3) Female2820 (50.7)Body mass index28.8 ± 6.9 \<18.51103 (1.9) 18.5--24.91577 (28.4) 25--29.91684 (30.3) 30+2196 (39.5)Ratio of family income to poverty 0--4.94199 (75.5) 5+1361 (24.5)Education level Less than 9th grade550 (9.9) 9--11th grades782 (14.1) High school graduate or equivalent1169 (21.0) Some college or AA degree1657 (29.8) College graduate or above1397 (25.2)Serum cotinine (ng/mL)52.1 ± 120.2Alcohol status \>12 drinks3413 (72.8) Less than 12 drinks1275 (27.2)Physical activity level Engaging moderately2297 (41.3) None3262 (58.7)Celiac disease18 (0.3)Liver problem219 (3.9)Weak/failing kidney200 (3.6)Kidney stones458 (8.3)Table 2Associations between 2-hydroxyfluorene (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valuePopulation attributable riskCeliac disease1073.3 (1478.6)599.0 (1059.9)0.2081.48 (0.28--7.88)0.630--Liver problem705.4 (1021.3)597.3 (1063.8)0.4140.93 (0.65--1.34)0.678--Weak/failing kidney567.1 (701.6)602.5 (1072.8)0.8051.14 (0.81--1.61)0.432--Kidney stones641.4 (984.7)597.5 (1070.3)0.6261.35 (1.02--1.78)0.0382.8 % (0.2--6.1 %)^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weightingTable 3Associations between 3-hydroxyfluorene (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valuePopulation attributable riskCeliac disease543.9 (790.2)294.4 (613.2)0.2522.03 (0.31--13.12)0.436--Liver problem339.3 (615.1)293.9 (614.2)0.5531.00 (0.66--1.52)0.994--Weak/failing kidney245.7 (402.1)297.5 (620.4)0.5350.98 (0.75--1.29)0.899--Kidney stones303.7 (547.2)295.1 (621.0)0.8701.35 (1.07--1.70)0.0152.8 % (0.4--3.6 %)^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weightingTable 4Associations between 9-hydroxyfluorene (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valuePopulation attributable riskCeliac disease583.8 (565.8)518.4 (869.6)0.8321.40 (0.88--2.22)0.148--Liver problem590.2 (774.0)516.3 (872.0)0.4950.91 (0.51--1.63)0.736--Weak/failing kidney604.8 (942.0)515.9 (866.1)0.4481.38 (0.69--2.75)0.335--Kidney stones561.0 (743.9)514.7 (880.3)0.5301.21 (0.98--1.50)0.075--^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weightingTable 5Associations between 1-hydroxyphenanthrene (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valuePopulation attributable riskCeliac disease240.4 (184.3)201.5 (286.0)0.7012.02 (0.71--5.71)0.173--Liver problem188.9 (172.3)202.4 (289.3)0.7040.78 (0.42--1.45)0.401--Weak/failing kidney188.3 (260.1)202.2 (286.6)0.7171.30 (0.72--2.34)0.367--Kidney stones217.5 (226.0)200.2 (291.0)0.4751.48 (1.08--2.03)0.0172.5 % (0.4--5.3 %)^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weightingTable 6Associations between 2-hydroxyphenanthrene (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valuePopulation attributable riskCeliac disease162.4 (153.9)108.4 (152.2)0.3172.06 (0.80--5.26)0.124--Liver problem119.6 (115.4)108.3 (153.5)0.5550.87 (0.46--1.65)0.645--Weak/failing kidney81.1 (83.8)109.6 (153.9)0.1640.95 (0.51--1.77)0.873--Kidney stones116.5 (133.5)107.8 (153.9)0.5001.43 (0.97--2.09)0.068--^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weightingTable 7Associations between 3-hydroxyphenanthrene (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valuePopulation attributable riskCeliac disease183.5 (187.2)122.3 (228.7)0.4501.82 (0.54--6.14)0.312--Liver problem134.4 (185.5)122.1 (230.1)0.6660.87 (0.44--1.71)0.666--Weak/failing kidney92.3 (109.8)123.5 (231.4)0.3141.00 (0.69--1.45)0.991--Kidney stones117.2 (132.0)123.0 (236.0)0.7641.35 (0.99--1.85)0.058--^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weightingTable 8Associations between 1-hydroxypyrene (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valuePopulation attributable riskCeliac disease193.1 (141.6)202.9 (330.0)0.9331.30 (0.29--5.83)0.721--Liver problem233.4 (359.1)201.8 (328.2)0.4421.00 (0.62--1.63)0.988--Weak/failing kidney136.9 (192.3)205.3 (333.0)0.1270.80 (0.63--1.01)0.057--Kidney stones204.2 (278.9)202.9 (334.3)0.9651.36 (1.05--1.77)0.0231.9 % (0.3--4.0 %)^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weightingTable 9Associations between 1-hydroxynapthalene (1-naphthol) (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valuePopulation attributable riskCeliac disease6372.8 (7289.4)37,428.0 (602,343.9)0.8841.34 (0.97--1.86)0.076--Liver problem187,972.7 (1,462,008.0)31,118.9 (537,358.8)0.0360.99 (0.80--1.22)0.930--Weak/failing kidney217,324.0 (1,585,249.0)31,089.0 (536,058.9)0.0220.91 (0.70--1.17)0.436--Kidney stones99,028.9 (1,035,260.0)31,252.8 (540,238.8)0.1841.04 (0.88--1.24)0.601--^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weightingTable 10Associations between 2-hydroxynapthalene (2-naphthol) (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valuePopulation attributable riskCeliac disease10,106.8 (10,404.5)8905.0 (12,106.0)0.7791.49 (0.78--2.86)0.214--Liver problem11,097.9 (14,134.9)8820.5 (12,002.4)0.1311.04 (0.66--1.62)0.868--Weak/failing kidney8867.4 (10,518.2)8912.5 (12,154.7)0.9780.78 (0.58--1.06)0.105--Kidney stones9490.2 (10,811.0)8839.1 (12,215.2)0.5251.25 (1.00--1.58)0.0541.3 % (0--3.0 %)^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weightingTable 11Associations between 4-hydroxyphenanthrene (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valuePopulation attributable riskCeliac disease41.4 (45.2)35.0 (51.4)0.7421.61 (1.14--2.26)0.0090.2 % (n/a)Liver problem48.0 (117.0)34.5 (46.8)0.0360.71 (0.37--1.37)0.291--Weak/failing kidney29.0 (32.5)35.3 (51.9)0.3611.14 (0.62--2.07)0.659--Kidney stones35.0 (40.5)35.1 (52.4)0.9831.33 (0.95--1.86)0.093--^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weighting

Discussion {#Sec10}
==========

Previous research synthesis {#Sec11}
---------------------------

As mentioned earlier, literature on the effects of PAHs on human health is less than the other environmental chemicals, such as heavy metals, pesticides, arsenic, and phthalates. This is particularly apparent in the relationship of PAHs and digestive conditions.

PAHs have been known as toxic chemicals and could affect renal function. Previously, PAHs were not found to be associated with renal cancer risk in Americans (Karami et al. [@CR6]) but associated with kidney damage in Italians (Lacquaniti et al. [@CR8]). The current findings in the present study were similar to those previous observations showing that PAHs were associated with kidney stones but not failing kidney in American adults. Animal studies using Swiss mouse and rats in vitro also presented that PAHs could damage the kidney (Krajka-Kuźniak and Baer-Dubowska [@CR7]; Roos [@CR10]; Bondy et al. [@CR2]; Bowes and Ramos [@CR3]). In other words, it is likely that PAHs could exacerbate kidney dysfunction but not necessarily lead to fatal events. One of the reasons might be that the study sample was not exposed to the exceeding toxic level. On the other hand, it was observed that people with celiac disease had higher levels of PAHs in the present study. However, no literature has addressed the potential link. Therefore, no comparison could be made and discussed.

Strengths and limitations {#Sec12}
-------------------------

The present study has a few strengths. First, this study was conducted in a large and nationally representative population with mixed ethnicities and socioeconomic status. Second, this is the first time to examine the risk effects of urinary PAHs on adult digestive conditions. However, there are also a few limitations that cannot be ignored. First, there could be still other emerging chemicals from the living environments through different channels/vehicles that we might not yet know and would need future research to further identify and examine. Second, other subtypes of disease of the digestive system were not available in the current limited dataset nor clinical measures for these specific diseases. Third, some disease events, such as celiac disease, were still suffering from small number in the statistical analysis due to the fact that it is not a very common disease. Therefore, some associations could be underestimated. Fourth, causality cannot be established in the present study due to the cross-sectional study design in nature. Future studies with a longitudinal study design to confirm or refute the current findings and, if at all, to understand the persisting risk effects along the life course from those environmental chemicals mentioned above would be suggested.

Research, practice, and policy implications {#Sec13}
-------------------------------------------

In summary, urinary PAHs were positively associated with adult celiac diseases and kidney stones. From the research perspective, longitudinal monitoring from observational studies and experimental research understanding mechanism would be suggested. From the law and human health perspectives, regulation of minimizing PAHs exposure for humans might need to be considered in future health and environmental policies and intervention programs.
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